Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/13/5d/f5/135df56a-9b63-ffad-9b95-f23279ec100b/mza_8001191650329673636.jpg/600x600bb.jpg
IDBR Infectious Disease Board Review
John Bennett, MD / Henry Masur, MD
22 episodes
6 days ago
The Infectious Disease Board Review (IDBR) Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification/recertification exam. This comprehensive review features exam-focused lectures presented by the Nation’s leading infectious disease experts, case-based reviews, online practice exams featuring over 500 ABIM-style and photo-based questions, and additional study guides and primers. https://www.idbrcourse.org/
Show more...
Medicine
Health & Fitness
RSS
All content for IDBR Infectious Disease Board Review is the property of John Bennett, MD / Henry Masur, MD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Infectious Disease Board Review (IDBR) Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification/recertification exam. This comprehensive review features exam-focused lectures presented by the Nation’s leading infectious disease experts, case-based reviews, online practice exams featuring over 500 ABIM-style and photo-based questions, and additional study guides and primers. https://www.idbrcourse.org/
Show more...
Medicine
Health & Fitness
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40768357/40768357-1715876268107-be39cae4504ee.jpg
Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD
IDBR Infectious Disease Board Review
3 minutes 29 seconds
1 year ago
Stopping PJP prophylaxis in HIV - Trip Gulick, MD/ Michael Saag, MD

A 44-year-old man was diagnosed with Pneumocystis pneumonia as his AIDS-defining illness and begun on antiretroviral therapy with 2 nucleosides and an integrase inhibitor during his hospitalization. He stabilizes and follows up for repeated outpatient visits with an HIV RNA consistently <20 copies/ml and a CD4 cell count of 44 that increased to 163 (at 3 months), 232 (at 6 months), 242 (at 9 months), and was repeated at 243 (at 12 months).


His current medications are: tenofovir alafenamide/emtricitabine, dolutegravir, trimethoprim-sulfa double strength daily, and azithromycin 1200 mg once weekly. He says he’s tired of taking pills and would like to stop some of them.


What do you recommend?

A. Stop tenofovir alafenamide/emtricitabine

B. Stop trimethoprim-sulfa

C. Stop azithromycin

D. Stop trimethoprim-sulfa and azithromycin

E. Continue the current regimen


⁠www.idbrcourse.org/⁠  © 2024 IDBR LLC | All Rights Reserved

IDBR Infectious Disease Board Review
The Infectious Disease Board Review (IDBR) Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification/recertification exam. This comprehensive review features exam-focused lectures presented by the Nation’s leading infectious disease experts, case-based reviews, online practice exams featuring over 500 ABIM-style and photo-based questions, and additional study guides and primers. https://www.idbrcourse.org/